SI-BONE Inc. (SIBN), a medical device company dedicated to addressing musculoskeletal disorders of the sacropelvic anatomy, has begun the year on a high note, showcasing robust performance in the first quarter of 2024.
The flagship product of the company is iFuse Implant System, a minimally invasive surgical treatment for sacroiliac joint disorders. The sacroiliac joint is the joint connection between the lower spine and the pelvis. Dysfunction in the sacroiliac joint is thought to cause low back pain and/or leg pain.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com